Jim Simons - Renaissance Technologies LLC 13F Activity & Position Changes (Q4 2022)

As of Dec 31, 2022, the Renaissance Technologies LLC portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Feb 13, 2023. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q4 2022, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q4 2022
AA
Alcoa Corporation
Sell
-2,305,700
Q4 2022
AADI
Aadi Bioscience, Inc.
Buy
+7,300
Q4 2022
AAL
American Airlines Group, Inc.
Sell
-58,800
Q4 2022
AAME
Atlantic American Corporation
Sell
-1,100
Q4 2022
AAN
Sell
-60,200
Q4 2022
AAOI
Applied Optoelectronics, Inc.
Sell
-10,700
Q4 2022
AAON
AAON, Inc.
Sell
-4,100
Q4 2022
AAPL
Apple Inc.
Buy
+5,870,078
Q4 2022
AAT
American Assets Trust, Inc.
Buy
+24,000
Q4 2022
AAXJ
iShares MSCI All Country Asia e
Buy
+2,400
Q4 2022
ABBNY
ABB Ltd.
Buy
+369,200
Q4 2022
ABBV
AbbVie Inc.
Sell
-26,606
Q4 2022
ABCB
Ameris Bancorp
Sell - Position Exit
-10,369
Q4 2022
ABCL
AbCellera Biologics Inc.
Sell
-858,400
Q4 2022
ABEO
Abeona Therapeutics Inc.
Sell
-5,500
Q4 2022
ABEV
Ambev S.A.
Buy
+162,400
Q4 2022
ABG
Asbury Automotive Group Inc
Sell - Position Exit
-13,200
Q4 2022
Buy
+1,700
Q4 2022
ABNB
Airbnb, Inc.
Buy
+1,323,719
Q4 2022
ABOS
Acumen Pharmaceuticals, Inc.
Buy - Position Entry
+32,300
Q4 2022
ABSI
Absci Corporation
Buy - Position Entry
+61,907
Q4 2022
ABT
Abbott Laboratories
Buy
+240,308
Q4 2022
ABUS
Arbutus Biopharma Corporation
Sell
-10,524
Q4 2022
AC
Associated Capital Group, Inc.
Sell
-700
Q4 2022
ACA
Arcosa, Inc.
Buy
+56,900
Q4 2022
ACAD
ACADIA Pharmaceuticals Inc.
Buy
+278,000
Q4 2022
ACCD
Accolade, Inc.
Sell
-89,900
Q4 2022
ACCO
Acco Brands Corporation
Buy
+34,100
Q4 2022
ACEL
Accel Entertainment, Inc.
Buy
+3,600
Q4 2022
ACET
Adicet Bio, Inc.
Buy - Position Entry
+29,700
Page 1 of 118